73539-001Level 3
LANTIDRA (DONISLECEL)
**Product type:** Cellular Therapy
**Active ingredient:** DONISLECEL
**Strength:** 5000 [arb'U]/400mL
**Dosage form:** Solution
**Route:** Intravascular
**Labeler:** CellTrans Inc.
**Marketing category:** BLA (BLA125734)
GET
/api/v1/systems/ndc_fda/nodes/73539-001Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.